Blue Jet Healthcare Limited (NSE: BLUEJET)

Market Cap	88.37B
Revenue (ttm)	6.95B
Net Income (ttm)	1.57B
Shares Out	173.47M
EPS (ttm)	9.08
PE Ratio	56.11
Forward PE	36.15
Dividend	1.00 (0.20%)
Ex-Dividend Date	n/a

Volume	698,420
Open	482.70
Previous Close	478.70
Day's Range	478.00 - 516.70
52-Week Range	319.50 - 538.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is hea...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 407
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2023, BLUEJET's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.